Basics Precision BioSciences, Inc. IPO Date: May 25, 2019 Sector: Healthcare Industry: Biotech Market Cap: $54.12M Activated in VL: True Average Daily Range Avg Daily Range: $0.25 | 3.74% Avg Daily Range (30 D): $0.18 | 3.62% Avg Daily Range (90 D): $0.21 | 4.03% Institutional Daily Volume Avg Daily Volume: .64M Avg Daily Volume (30 D): .17M Avg Daily Volume (90 D): .31M Trade Size Avg Trade Size (Sh.): 175 Avg Trade Size (Sh.) (30 D): 196 Avg Trade Size (Sh.) (90 D): 145 Institutional Trades Total Inst.Trades: 319 Avg Inst. Trade: $1.41M Avg Inst. Trade (30 D): $2.64M Avg Inst. Trade (90 D): $2.64M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.55M Avg Closing Trade (30 D): $1.21M Avg Closing Trade (90 D): $1.21M Avg Closing Volume: 6.87K         News Mar 5, 2025 @ 6:00 PM CAR T-cell Therapy Clinical Trial Pipeline Experie... Source: Delveinsight Sep 10, 2024 @ 9:00 AM Global Genetic Engineering Market Size To Worth US... Source: Spherical Insights & Consulting Sep 10, 2024 @ 8:51 AM Gene Editing Therapeutics Market Forecast 2024-202... Source: Researchandmarkets.Com May 29, 2024 @ 1:55 PM Does Precision BioSciences (DTIL) Have the Potenti... Source: Zacks Equity Research May 16, 2024 @ 6:00 PM Deep Dive Into Precision BioSciences Stock: Analys... Source: Benzinga Insights Financials   TTM Q4 2024 FY 2024 Basic EPS $1.05 $-2.82 $1.05 Diluted EPS $1.04 $-2.74 $1.04 Revenue $ 68.7M $ .64M $ 68.7M Gross Profit $ $ $ Net Income / Loss $ 7.17M $ -17.75M $ 7.17M Operating Income / Loss $ -26.16M $ -24.85M $ -26.16M Cost of Revenue $ $ $ Net Cash Flow $ -8.21M $ -12.86M $ -8.21M PE Ratio 0.00     Splits Feb 14, 2024:   30:1